Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019.
Garcia-Vidal C, Moreno-García E, Hernández-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N, Linares L, Rico V, Cardozo C, Martínez JA, García F, Mensa J, Castro P, Nicolás JM, Muñoz J, Vidal D, Soriano A; COVID19-Researchers. Garcia-Vidal C, et al. Clin Infect Dis. 2022 Jan 7;74(1):127-132. doi: 10.1093/cid/ciaa964. Clin Infect Dis. 2022. PMID: 32649747 Free PMC article.
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis.
Ripa M, Rodríguez-Núñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F, Morata L, De La Calle C, Del Rio A, Garcia-Vidal C, Ortega MDM, Guerrero-León MLA, Feher C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA. Ripa M, et al. J Antimicrob Chemother. 2017 Dec 1;72(12):3443-3452. doi: 10.1093/jac/dkx315. J Antimicrob Chemother. 2017. PMID: 28961801
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis-authors' response.
Ripa M, Rodríguez-Nuñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F, Morata L, De La Calle C, Del Río A, Garcia-Vidal C, Ortega MDM, Guerrero-León MLA, Fehér C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA. Ripa M, et al. J Antimicrob Chemother. 2018 Jun 1;73(6):1732-1733. doi: 10.1093/jac/dky063. J Antimicrob Chemother. 2018. PMID: 29506238 No abstract available.
Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.
Garcia-Vidal C, Cardozo-Espinola C, Puerta-Alcalde P, Marco F, Tellez A, Agüero D, Romero-Santana F, Díaz-Beyá M, Giné E, Morata L, Rodríguez-Núñez O, Martinez JA, Mensa J, Esteve J, Soriano A. Garcia-Vidal C, et al. PLoS One. 2018 Jun 28;13(6):e0199531. doi: 10.1371/journal.pone.0199531. eCollection 2018. PLoS One. 2018. PMID: 29953464 Free PMC article.
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa.
Rodríguez-Núñez O, Ripa M, Morata L, de la Calle C, Cardozo C, Fehér C, Pellicé M, Valcárcel A, Puerta-Alcalde P, Marco F, García-Vidal C, Del Río A, Soriano A, Martínez-Martínez JA. Rodríguez-Núñez O, et al. J Glob Antimicrob Resist. 2018 Dec;15:136-139. doi: 10.1016/j.jgar.2018.07.010. Epub 2018 Jul 20. J Glob Antimicrob Resist. 2018. PMID: 30036695
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P, Cardozo C, Suárez-Lledó M, Rodríguez-Núñez O, Morata L, Fehér C, Marco F, Del Río A, Martínez JA, Mensa J, Rovira M, Esteve J, Soriano A, Garcia-Vidal C. Puerta-Alcalde P, et al. Clin Microbiol Infect. 2019 Apr;25(4):447-453. doi: 10.1016/j.cmi.2018.07.026. Epub 2018 Aug 7. Clin Microbiol Infect. 2019. PMID: 30096417 Free article.
87 results